MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation

Zhiqiang Pang,Yao Lu,Guangyan Zhou,Fiona Hui,Lei Xu,Charles Viau,Aliya F Spigelman,Patrick E MacDonald,David S Wishart,Shuzhao Li,Jianguo Xia
DOI: https://doi.org/10.1093/nar/gkae253
IF: 14.9
2024-04-08
Nucleic Acids Research
Abstract:We introduce MetaboAnalyst version 6.0 as a unified platform for processing, analyzing, and interpreting data from targeted as well as untargeted metabolomics studies using liquid chromatography - mass spectrometry (LC–MS). The two main objectives in developing version 6.0 are to support tandem MS (MS2) data processing and annotation, as well as to support the analysis of data from exposomics studies and related experiments. Key features of MetaboAnalyst 6.0 include: (i) a significantly enhanced Spectra Processing module with support for MS2 data and the asari algorithm; (ii) a MS2 Peak Annotation module based on comprehensive MS2 reference databases with fragment-level annotation; (iii) a new Statistical Analysis module dedicated for handling complex study design with multiple factors or phenotypic descriptors; (iv) a Causal Analysis module for estimating metabolite - phenotype causal relations based on two-sample Mendelian randomization, and (v) a Dose-Response Analysis module for benchmark dose calculations. In addition, we have also improved MetaboAnalyst's visualization functions, updated its compound database and metabolite sets, and significantly expanded its pathway analysis support to around 130 species. MetaboAnalyst 6.0 is freely available at https://www.metaboanalyst.ca.
biochemistry & molecular biology
What problem does this paper attempt to address?
The main issues this paper attempts to address include the following: 1. **Support for tandem mass spectrometry (MS2) data processing and annotation**: - Untargeted metabolomics data generated by high-resolution liquid chromatography-mass spectrometry (LC-MS) typically contain thousands of peaks with unknown chemical identities. To aid in compound identification, tandem mass spectrometry (MS2) data are often collected during experiments. The paper describes how MetaboAnalyst 6.0 supports the processing and annotation of MS2 data to improve the accuracy of compound annotation and functional interpretation. 2. **Support for exposomics data analysis**: - Exposomics is an emerging field that focuses on all exposures an individual encounters throughout their lifetime. These studies often involve complex phenotypic data, requiring more sophisticated data analysis and visualization methods to consider multiple factors or covariates. The paper describes how MetaboAnalyst 6.0 supports the needs of these complex data analyses. 3. **Causal relationship analysis**: - Understanding the causal relationships between metabolites and phenotypes is crucial in metabolomics and exposomics. The paper describes how causal relationship analysis can be performed in MetaboAnalyst 6.0 using the two-sample Mendelian randomization (2SMR) method to assess the causal effects of metabolites on specific phenotypes. 4. **Dose-response analysis**: - Dose-response analysis is used in toxicology and pharmacology to understand how different concentrations of chemicals affect biological systems, playing a key role in risk assessment. The paper describes how dose-response analysis can be performed in MetaboAnalyst 6.0, including dose-response curve fitting and benchmark dose (BMD) calculation. 5. **Enhanced functional analysis and data visualization**: - The paper describes how functional analysis for untargeted metabolomics is enhanced in MetaboAnalyst 6.0, including improved MS2 data processing and annotation, as well as enhanced data visualization support, such as interactive 3D plots and clustered heatmaps. In summary, this paper aims to make MetaboAnalyst 6.0 a more comprehensive and powerful platform for metabolomics data analysis by introducing new modules and features, with a particular focus on the complex needs of untargeted metabolomics and exposomics research.